Nate Silver

@NateSilver538 ↗

Deleted No

Hibernated No

Last Checked March 3, 2021

Created

Tue Feb 16 14:54:55 +0000 2021

Likes

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

Nate Silver @NateSilver538

@notdred Yeah as usual it's incredibly hard to figure out what doses would actually be available on which schedules. — PolitiTweet.org

Posted Feb. 16, 2021

Preceded By

Nate Silver @NateSilver538

Anyway, I don't think AstraZeneca is in the same bucket as J&J. The clinical trial data is a lot more complicated and so is the question of what role it serves when we have 3 other vaccines to deploy (again, presuming J&J approval). I'd want the FDA to think carefully on it. — PolitiTweet.org

Posted Feb. 16, 2021

Followed By

Nate Silver @NateSilver538

@EdBelongia Possibly another dumb question but wouldn't the presence of other, possibly more effective vaccines affect the cost-benefit calculation for the EUA? (i.e. there's less benefit if the vaccine has no comparative advantages over others). Or does it evaluate each vaccine in a vacuum? — PolitiTweet.org

Posted Feb. 16, 2021